SCHEMBL8440252

SCHEMBL8440252

COc1ccc(O)c(-c2cc(OC)ccc2O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.61
ALDH1A1 P00352 5/20 0.59
MEN1 O00255 4/20 0.59
MAPT P10636 4/20 0.59
KMT2A Q03164 4/20 0.59
GAA P10253 4/20 0.59
KDM4E B2RXH2 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
THRB P10828 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
MCL1 Q07820 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ERN1 O75460 1/20 0.55
RAB9A P51151 3/20 0.54
HPGD P15428 2/20 0.54
ALOX15 P16050 2/20 0.54
LMNA P02545 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
APP P05067 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763172 1.00 NPC1 (0.61) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL11616701 0.91 NPC1 (0.54) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL9068308 0.89 NPC1 (0.53) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL29541984 0.87 KMT2A (0.61) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL29083062 0.84 GAA (0.52) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL9638313 0.83 MAPT (0.60) NPC1MEN1MAPTKMT2AGAA
SCHEMBL17274611 0.83 NPC1 (0.47) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL27613014 0.83 ALDH1A1 (0.55) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL8940685 0.83 ALDH1A1 (0.55) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL67498 0.82 ALDH1A1 (0.61) NPC1ALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104053663-B Process for purifying organodiphosphite compounds 巴斯夫欧洲公司 2017-07-04 CN claimed
US-10759997-B2 Polymerizable compound, liquid crystal medium containing same and liquid crystal display device SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2020-09-01 US disclosed
CN-104053663-B Process for purifying organodiphosphite compounds 巴斯夫欧洲公司 2017-07-04 CN disclosed
CN-104837853-B Bisphosphite mixture and use thereof as catalyst mixture in hydroformylation 赢创德固赛有限公司 2017-05-10 CN disclosed
EP-0757672-B1 MONODENTATE PHOSPHITE AND NICKEL CATALYST COMPOSITION FOR MONOOLEFIN HYDROCYANATION DU PONT (US) 1999-06-16 EP disclosed
EP-0757672-A1 MONODENTATE PHOSPHITE AND NICKEL CATALYST COMPOSITION FOR MONOOLEFIN HYDROCYANATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-02-12 EP disclosed
EP-0590613-B1 Improved hydroformylation process UNION CARBIDE CHEM PLASTIC (US) 1997-01-08 EP disclosed
US-5543536-A Monodentate phosphite and nickel catalyst composition for monoolefin hydrocyanation E. I. DU PONT DE NEMOURS AND COMPANY (US) 1996-08-06 US disclosed
US-5512696-A HYDROCYANATION OF ALIPHATIC MONOETHYLENICALLY UNSATURATEDCOMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1996-04-30 US disclosed
WO-1995029153-A1 MONODENTATE PHOSPHITE AND NICKEL CATALYST COMPOSITION FOR MONOOLEFIN HYDROCYANATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-11-02 WO disclosed
EP-0590613-A2 Improved hydroformylation process UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-04-06 EP disclosed
US-5288918-A Using a rhodium-organobisphosphite complex catalyst UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759997-B2 Polymerizable compound, liquid crystal medium containing same and liquid crystal display device BPHL, KLK3, NEFM NPC1 4521/4885ALDH1A1 2237/4885MEN1 1931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.